Ian Sosso
Managing Partner at Monte Carlo Capital
Monaco
Overview
Work Experience
Founder and Managing Partner
2009 - Current
I founded Monte Carlo Capital (MCC) initially as an angel investor deploying my own capital. Over the years, MCC evolved into a venture firm that combines a fund with SPVs, investing in early-stage technology companies with the potential to solve big problems or drive 10X efficiency improvements in large markets. As an angel investor, I led over 50 investments across 23 companies, often across multiple rounds. MCC has invested over $7M in a single business in successive financings. Today, we no longer lead rounds, but act as highly strategic co-investors alongside world-class VCs. Today, MCC invests in seed-stage technology-driven businesses in the US, UK, and Europe across sectors. Our hybrid investment model includes: 🔹 A fund (now closed)– Writing €250K–€350K first checks in 30 companies. The next fund will be launched Q1 2026 🔹 SPVs for Co-Investment with the Fund – 7 deals per year, ranging from €500K to €1M, enabling investors to deploy significantly more capital beyond the fund’s capacity. 🔹 Backing Exceptional Founders – Co-investing alongside top global VCs like Valor Equity Partners, Insight Partners, Seraphim Space, FJ Labs, Kima Ventures, Y Combinator, Wellington, Aglaé Ventures, Panakes, and more. Join Our Investor Network MCC’s investor base is primarily HNWIs and family principals who seek access to top-tier venture deals. If you’re interested in exclusive investment opportunities in early-stage technology, apply here: montecarlocap.com/investors/
Adjunct Professor
2016 - 2021
I teached a 30 hour class on Venture Capital to MBA and Finance MSc students. Class rated by students 4.7/5.0 to 4.8/5.0.
Regional Managing Director - Head of Global Markets Asia Pacific
2004 - 2009
Responsible for overseeing and growing all the financial markets businesses in Asia (Trading, Sales, Structuring) across asset classes (Equity Derivatives, FX, Rates, Credit, Precious Metals, Alternative Investments). Ran the trading floors of HK, Singapore and Shanghai. Built the structured products businesses from scratch.
Head of FX structuring
2003 - 2004
Vice President - Structuring - Derivatives and Structured Products
2001 - 2003
Vice President - Structuring - Derivatives and Structured Products - All asset classes
1999 - 2001
Morgan Health is the healthcare investment arm of JPMorgan Chase.
Director - Hedge Funds Derivatives Sales
1998 - 1999
Associate Director - Exotics Options Sales and Structuring - Asia
1997 - 1998
UBS Realty Investors is an institutional investment advisor that managed real estate equity assets on behalf of its clients.
FX Options Sales and Structuring
1995 - 1997
FX Options Sales / Eurobond Trading / FX Forwards Trading
1993 - 1995
Oversees relationships with the venture capital community and connects their portfolio companies to the right people at HSBC.